Skip to main content
Erschienen in: The European Journal of Health Economics 1/2021

11.04.2020 | Editorial

Do European pharmacists really have to trespass on medicine?

verfasst von: Livio Garattini, Anna Padula, Nicholas Freemantle

Erschienen in: The European Journal of Health Economics | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Excerpt

Pharmacy has been traditionally regarded as an intermediate discipline between health and chemistry [1], rooted in drug development, production, and compounding. The vast majority of pharmacists used to make drugs until the 1950s, no matter whether they worked in hospital or in community. These tasks have been almost lost with the large-scale manufacturing of pharmaceuticals by industry, and dispensing remains the main historical activity of pharmacists. In the long run, these changes have weakened the combination of the pharmacist's profession and education [2]. Although still focused on scientific subjects (for instance biology, chemistry, and physics), education has been inevitably affected by the domestic regulation of the profession, especially in the community domain, still by far the most important labor market for pharmacy graduates [3]. At present, pharmacy education has found a wide range of uneven solutions in European countries [2], starting from the shortest duration of graduation, which ranges from three (in Finland, Norway and Sweden) to six years (in France and The Netherlands)—with Italy the only continental country that has lengthened the duration in recent decades from 4 to 5 years. …
Literatur
1.
Zurück zum Zitat Pearson, G.J.: Evolution in the practice of pharmacy—not a revolution! CMAJ 176(9), 1295–1296 (2007)CrossRef Pearson, G.J.: Evolution in the practice of pharmacy—not a revolution! CMAJ 176(9), 1295–1296 (2007)CrossRef
2.
Zurück zum Zitat Garattini, L., Padula, A.: From pharmacy faculty to pharmacy shop: still a logical pathway in Europe? Drugs Ther Perspect. 34(2), 85–88 (2018)CrossRef Garattini, L., Padula, A.: From pharmacy faculty to pharmacy shop: still a logical pathway in Europe? Drugs Ther Perspect. 34(2), 85–88 (2018)CrossRef
3.
Zurück zum Zitat Mossialos, E., Courtin, E., Naci, H., Benrimoj, S., Bouvy, M., Farris, K., Noyce, P., Sketris, I.: From ‘retailers’ to health care providers: transforming the role of community pharmacists in chronic disease management. Health Policy 119, 628–639 (2015)CrossRef Mossialos, E., Courtin, E., Naci, H., Benrimoj, S., Bouvy, M., Farris, K., Noyce, P., Sketris, I.: From ‘retailers’ to health care providers: transforming the role of community pharmacists in chronic disease management. Health Policy 119, 628–639 (2015)CrossRef
4.
Zurück zum Zitat Moltó-Puigmartí, C., Vonk, R., van Ommeren, G., Hegger, I.: A logic model for pharmaceutical care. J Health Serv Res Policy. 23(3), 148–157 (2018)CrossRef Moltó-Puigmartí, C., Vonk, R., van Ommeren, G., Hegger, I.: A logic model for pharmaceutical care. J Health Serv Res Policy. 23(3), 148–157 (2018)CrossRef
5.
Zurück zum Zitat Kehrer, J.P., Eberhart, G., Wing, M., Horon, K.: Pharmacy's role in a modern health continuum. Can Pharm J. 146(6), 321–324 (2013)CrossRef Kehrer, J.P., Eberhart, G., Wing, M., Horon, K.: Pharmacy's role in a modern health continuum. Can Pharm J. 146(6), 321–324 (2013)CrossRef
6.
Zurück zum Zitat Atkinson, J.: The country profiles of the PHARMINE survey of european higher educational institutions delivering pharmacy education and training. Pharmacy (Basel). 5(3), E34 (2017)CrossRef Atkinson, J.: The country profiles of the PHARMINE survey of european higher educational institutions delivering pharmacy education and training. Pharmacy (Basel). 5(3), E34 (2017)CrossRef
7.
Zurück zum Zitat Franklin, B.D., van Mil, J.W.: Defining clinical pharmacy and pharmaceutical care. Pharm World Sci 27(3), 137 (2005)CrossRef Franklin, B.D., van Mil, J.W.: Defining clinical pharmacy and pharmaceutical care. Pharm World Sci 27(3), 137 (2005)CrossRef
9.
Zurück zum Zitat Garattini, L., Padula, A.: Hospital pharmacists in Europe: between warehouse and prescription pad? Pharmacoecon Open. 2(3), 221–224 (2018)CrossRef Garattini, L., Padula, A.: Hospital pharmacists in Europe: between warehouse and prescription pad? Pharmacoecon Open. 2(3), 221–224 (2018)CrossRef
11.
Zurück zum Zitat Anonymous. The European statements of hospital pharmacy. Eur J Hosp Pharm 2014;21:256–8. Anonymous. The European statements of hospital pharmacy. Eur J Hosp Pharm 2014;21:256–8.
12.
Zurück zum Zitat Frontini, R., Miharija-Gala, T., Sykora, J.: EAHP survey 2010 on hospital pharmacy in Europe: parts 4 and 5 Clinical services and patient safety. Eur J Hosp Pharm 20, 69–73 (2013)CrossRef Frontini, R., Miharija-Gala, T., Sykora, J.: EAHP survey 2010 on hospital pharmacy in Europe: parts 4 and 5 Clinical services and patient safety. Eur J Hosp Pharm 20, 69–73 (2013)CrossRef
13.
Zurück zum Zitat Garattini, L., Padula, A.: Defensive medicine in Europe: a 'full circle'? Eur J Health Econ. 21(2), 165–170 (2020)CrossRef Garattini, L., Padula, A.: Defensive medicine in Europe: a 'full circle'? Eur J Health Econ. 21(2), 165–170 (2020)CrossRef
14.
Zurück zum Zitat Rothberg, M.B., Class, J., Bishop, T.F., Friderici, J., Kleppel, R., Lindenauer, P.K.: The cost of defensive medicine on three hospital medicine services. JAMA Intern Med. 174(11), 1867–1868 (2014)CrossRef Rothberg, M.B., Class, J., Bishop, T.F., Friderici, J., Kleppel, R., Lindenauer, P.K.: The cost of defensive medicine on three hospital medicine services. JAMA Intern Med. 174(11), 1867–1868 (2014)CrossRef
15.
Zurück zum Zitat Garattini, L., Padula, A.: Pharmaceutical care in Italy and other European countries: between care and commerce? Postgrad Med. 130(1), 52–54 (2018)CrossRef Garattini, L., Padula, A.: Pharmaceutical care in Italy and other European countries: between care and commerce? Postgrad Med. 130(1), 52–54 (2018)CrossRef
16.
Zurück zum Zitat Teichert, M., Schoenmakers, T., Kylstra, N., et al.: Quality indicators for pharmaceutical care: a comprehensive set with national scores for Dutch community pharmacies. Int J Clin Pharm. 38(4), 870–879 (2016)CrossRef Teichert, M., Schoenmakers, T., Kylstra, N., et al.: Quality indicators for pharmaceutical care: a comprehensive set with national scores for Dutch community pharmacies. Int J Clin Pharm. 38(4), 870–879 (2016)CrossRef
17.
Zurück zum Zitat Garattini, L., van de Vooren, K., Curto, A.: Will the reform of community pharmacies in Italy be of benefit to patients or the Italian National Health Service? Drugs Ther Perspect. 28(11), 23–26 (2012) Garattini, L., van de Vooren, K., Curto, A.: Will the reform of community pharmacies in Italy be of benefit to patients or the Italian National Health Service? Drugs Ther Perspect. 28(11), 23–26 (2012)
18.
Zurück zum Zitat Santuari, A.: Legal and organisational innovation in the Italian pharmacy system: commercial vs public interest. Health Econ Policy Law. 12(4), 495–513 (2017)CrossRef Santuari, A.: Legal and organisational innovation in the Italian pharmacy system: commercial vs public interest. Health Econ Policy Law. 12(4), 495–513 (2017)CrossRef
19.
Zurück zum Zitat Anonymous. The definition of clinical pharmacy. American College of Clinical Pharmacy. Pharmacotherapy. 2008;28(6):816–7. Anonymous. The definition of clinical pharmacy. American College of Clinical Pharmacy. Pharmacotherapy. 2008;28(6):816–7.
20.
Zurück zum Zitat Hepler, C.D., Strand, L.M.: Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 47(3), 533–543 (1990)PubMed Hepler, C.D., Strand, L.M.: Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 47(3), 533–543 (1990)PubMed
21.
Zurück zum Zitat Babar ZU, Kousar R, Murtaza G, Azhar S, Khan SA, Curley L. Randomized controlled trials covering pharmaceutical care and medicines management: a systematic review of literature. Res Social Adm Pharm. 2017.pii: S1551–7411(17)30473–4. Babar ZU, Kousar R, Murtaza G, Azhar S, Khan SA, Curley L. Randomized controlled trials covering pharmaceutical care and medicines management: a systematic review of literature. Res Social Adm Pharm. 2017.pii: S1551–7411(17)30473–4.
22.
Zurück zum Zitat Hill, P.: Pharmaceutical care RIP? Int J Pharm Pract. 20(1), 2–3 (2012)CrossRef Hill, P.: Pharmaceutical care RIP? Int J Pharm Pract. 20(1), 2–3 (2012)CrossRef
23.
Zurück zum Zitat Dreischulte, T., Fernandez-Llimos, F.: Current perceptions of the term clinical pharmacy and its relationship to pharmaceutical care: a survey of members of the European Society of Clinical Pharmacy. Int J Clin Pharm. 38(6), 1445–1446 (2016)CrossRef Dreischulte, T., Fernandez-Llimos, F.: Current perceptions of the term clinical pharmacy and its relationship to pharmaceutical care: a survey of members of the European Society of Clinical Pharmacy. Int J Clin Pharm. 38(6), 1445–1446 (2016)CrossRef
24.
Zurück zum Zitat Naß, J., Banerjee, M., Efferth, T., Wohlmann, A.: Pharmaceutical care as narrative practice? Rethinking patient-centered care through a pharmacist’s perspective. Int J Clin Pharm. 38(6), 1346–1349 (2016)CrossRef Naß, J., Banerjee, M., Efferth, T., Wohlmann, A.: Pharmaceutical care as narrative practice? Rethinking patient-centered care through a pharmacist’s perspective. Int J Clin Pharm. 38(6), 1346–1349 (2016)CrossRef
25.
Zurück zum Zitat Griese-Mammen, N., Hersberger, K.E., Messerli, M., Leikola, S., Horvat, N., van Mil, J.W.F., Kos, M.: PCNE definition of medication review: reaching agreement. Int J Clin Pharm. 40(5), 1199–1208 (2018)CrossRef Griese-Mammen, N., Hersberger, K.E., Messerli, M., Leikola, S., Horvat, N., van Mil, J.W.F., Kos, M.: PCNE definition of medication review: reaching agreement. Int J Clin Pharm. 40(5), 1199–1208 (2018)CrossRef
26.
Zurück zum Zitat Blenkinsopp, A., Bond, C., Raynor, D.K.: Medication reviews. Br J Clin Pharmacol. 74(4), 573–580 (2012)CrossRef Blenkinsopp, A., Bond, C., Raynor, D.K.: Medication reviews. Br J Clin Pharmacol. 74(4), 573–580 (2012)CrossRef
27.
Zurück zum Zitat Lombardi, N., Wei, L., Ghaleb, M., Pasut, E., Leschiutta, S., Rossi, P., Troncon, M.G.: Evaluation of the implementation of a clinical pharmacy service on an acute internal medicine ward in Italy. BMC Health Serv Res. 18(1), 259 (2018)CrossRef Lombardi, N., Wei, L., Ghaleb, M., Pasut, E., Leschiutta, S., Rossi, P., Troncon, M.G.: Evaluation of the implementation of a clinical pharmacy service on an acute internal medicine ward in Italy. BMC Health Serv Res. 18(1), 259 (2018)CrossRef
28.
Zurück zum Zitat De Rijdt, T., Willems, L., Simoens, S.: Hospital pharmacists versus hospital administrators: a struggle for clinical pharmacy services. Expert Rev Pharmacoecon Outcomes Res. 9(6), 497–498 (2009)CrossRef De Rijdt, T., Willems, L., Simoens, S.: Hospital pharmacists versus hospital administrators: a struggle for clinical pharmacy services. Expert Rev Pharmacoecon Outcomes Res. 9(6), 497–498 (2009)CrossRef
29.
Zurück zum Zitat Garattini, L., Padula, A.: Dutch guidelines for economic evaluation: 'from good to better' in theory but further away from pharmaceuticals in practice? J R Soc Med. 110(3), 98–103 (2017)CrossRef Garattini, L., Padula, A.: Dutch guidelines for economic evaluation: 'from good to better' in theory but further away from pharmaceuticals in practice? J R Soc Med. 110(3), 98–103 (2017)CrossRef
30.
Zurück zum Zitat Gallagher, J., McCarthy, S., Byrne, S.: Economic evaluations of clinical pharmacist interventions on hospital inpatients: a systematic review of recent literature. Int J Clin Pharm. 36(6), 1101–1114 (2014)CrossRef Gallagher, J., McCarthy, S., Byrne, S.: Economic evaluations of clinical pharmacist interventions on hospital inpatients: a systematic review of recent literature. Int J Clin Pharm. 36(6), 1101–1114 (2014)CrossRef
31.
Zurück zum Zitat Campbell, G., Auyeung, V., McRobbie, D.: Clinical pharmacy services in a London hospital, have they changed? Int J Clin Pharm. 35(5), 688–691 (2013)CrossRef Campbell, G., Auyeung, V., McRobbie, D.: Clinical pharmacy services in a London hospital, have they changed? Int J Clin Pharm. 35(5), 688–691 (2013)CrossRef
32.
Zurück zum Zitat Garattini, L., Padula, A.: ‘Appropriateness’ in Italy: a ‘magic word’ in pharmaceuticals? Appl Health Econ Health Policy. 15(1), 1–3 (2017)CrossRef Garattini, L., Padula, A.: ‘Appropriateness’ in Italy: a ‘magic word’ in pharmaceuticals? Appl Health Econ Health Policy. 15(1), 1–3 (2017)CrossRef
33.
Zurück zum Zitat Soares, I.B., Imfeld-Isenegger, T.L., Makovec, U.N., Horvat, N., Kos, M., Arnet, I., Hersberger, K.E., Costa, F.A.: A survey to assess the availability, implementation rate and remuneration of pharmacist-led cognitive services throughout Europe. Res Social Adm Pharm. 16(1), 41–47 (2020)CrossRef Soares, I.B., Imfeld-Isenegger, T.L., Makovec, U.N., Horvat, N., Kos, M., Arnet, I., Hersberger, K.E., Costa, F.A.: A survey to assess the availability, implementation rate and remuneration of pharmacist-led cognitive services throughout Europe. Res Social Adm Pharm. 16(1), 41–47 (2020)CrossRef
34.
Zurück zum Zitat Garattini, L., Curto, A., Padula, A.: Reimbursable drug classes and ceilings in Italy: why not only one? Eur J Health Econ. 17(8), 923–926 (2016)CrossRef Garattini, L., Curto, A., Padula, A.: Reimbursable drug classes and ceilings in Italy: why not only one? Eur J Health Econ. 17(8), 923–926 (2016)CrossRef
Metadaten
Titel
Do European pharmacists really have to trespass on medicine?
verfasst von
Livio Garattini
Anna Padula
Nicholas Freemantle
Publikationsdatum
11.04.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
The European Journal of Health Economics / Ausgabe 1/2021
Print ISSN: 1618-7598
Elektronische ISSN: 1618-7601
DOI
https://doi.org/10.1007/s10198-020-01185-w

Weitere Artikel der Ausgabe 1/2021

The European Journal of Health Economics 1/2021 Zur Ausgabe